Latest Indonesia News

Cue Energy Resources Limited’s Independent Board Committee has unanimously advised shareholders to reject Horizon Oil Limited’s off-market takeover offer, citing undervaluation and significant risks. Shareholders are urged to take no action in response to the offer.

PT Aneka Tambang Tbk (ANTAM) reported a historic financial year in 2025, with revenue up 22% and net profit more than doubling to Rp7.92 trillion, driven by strong domestic demand and operational efficiency. The company also navigates evolving Indonesian mining regulations and ongoing legal challenges as it invests in downstream nickel projects.

SportsHero Limited has secured a major content deal with Playades, adding over 400 popular mobile games to its HeroPlay platform and boosting subscriber growth in Southeast Asia ahead of the FIFA World Cup 2026.

iCandy Interactive confirms its removal from the ASX on 1 April 2026, shifting focus to a potential NYSE American listing for its key asset, Lemon Sky Studios.

Firebrick Pharma has secured its first regulatory approval for Nasodine Nasal Spray in Indonesia, paving the way for entry into Southeast Asia’s largest market. This milestone marks a significant step in the company’s international expansion strategy.

Ovanti Limited has secured $711,200 through a discounted share placement to professional investors, aiming to support its global operations and expansion into the US buy now, pay later market.

Triangle Energy has secured joint funding with Tetragon and Winchester Energy to undertake a strategic exploration study in Indonesia, potentially paving the way for a new production sharing contract.

Winchester Limited has partnered with Triangle Energy and Tetragon Energy in a joint study for offshore Indonesian oil and gas exploration, securing an option to acquire a 24.5% interest in any awarded Petroleum Sharing Contract.

Cue Energy Resources has advised shareholders to hold off on any action following Horizon Oil's dispatch of a Replacement Bidder’s Statement for its unsolicited takeover offer. A formal response and recommendation from Cue’s Independent Board Committee is expected by early April.

Recce Pharmaceuticals is progressing its Phase 3 clinical trial of RECCE 327, a novel synthetic antibiotic targeting multidrug-resistant infections, with interim data from Indonesia supporting registration plans across ASEAN by 2026.

Bass Oil has received regulatory approval to award the drilling contract for its Bunian 6 well in Indonesia, aiming to add 500 barrels of oil per day to current production by mid-year.

Horizon Oil has released a first supplementary and replacement bidder’s statement for its off-market takeover offer for Cue Energy, proposing a mix of cash and shares that values Cue at a 10-14% premium. The deal aims to create a diversified oil and gas producer across Asia-Pacific with significant synergies.